1.
Andrew Chase, Catherine Bryant, Joannah Score, Nicholas C.P. Cross. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome. Haematologica 2013;98(1):103-106; https://doi.org/10.3324/haematol.2012.066407.